Article Information
History
- April 28, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Imogen G. Franklin1,*,
- Paul Milne2,*,
- Jordan Childs1,
- Róisín M. Boggan1,
- Isabel Barrow1,3,
- Conor Lawless1,
- Gráinne S Gorman1,3,
- Yi Shiau Ng1,3,
- Matthew Collin2,+,$,
- Oliver M. Russell1,+ and
- Sarah J. Pickett1,+,$
- 1Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne
- 2Haematopoiesis and Immunogenomics Laboratory, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne
- 3NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne
- ↵$Corresponding authors: Sarah Pickett: Wellcome Centre for Mitochondrial Research, 4th Floor Cookson Building, Medical School, Framlington Place, Newcastle-upon-Tyne, NE2 4HH, UK. Tel. +44 191 208 3084; E-mail. sarah.pickett{at}ncl.ac.uk, Matthew Collin: Haematopoiesis and Immunogenomics Laboratory, Room M3.127, 3rd Floor Leech Building, Medical School, Framlington Place, Newcastle-upon-Tyne, NE2 4HH, UK. Tel. +44 191 2082795; E-mail. matthew.collin{at}ncl.ac.uk
↵* and + denote equal contributions